J.M. van Laar

819 total citations
23 papers, 492 citations indexed

About

J.M. van Laar is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, J.M. van Laar has authored 23 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 7 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in J.M. van Laar's work include Systemic Lupus Erythematosus Research (6 papers), Systemic Sclerosis and Related Diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). J.M. van Laar is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Systemic Sclerosis and Related Diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). J.M. van Laar collaborates with scholars based in Netherlands, Austria and Taiwan. J.M. van Laar's co-authors include A. M. M. Miltenburg, M. R. Daha, Ronella de Kuiper, F. C. Breedveld, Ruth Fritsch‐Stork, Roger E. G. Schutgens, A. Titia Lely, S.C. Mastbergen, Lize F. D. van Vulpen and M. E. R. van Meegeren and has published in prestigious journals such as Radiology, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

J.M. van Laar

23 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.M. van Laar Netherlands	11	232	207	84	81	59	23	492
Antónia Szántó Hungary	12	239 1.0×	253 1.2×	41 0.5×	34 0.4×	32 0.5×	30	607
Andrea Váncsa Hungary	12	305 1.3×	139 0.7×	34 0.4×	40 0.5×	31 0.5×	29	566
Ildikó Fanny Horváth Hungary	12	191 0.8×	177 0.9×	67 0.8×	35 0.4×	32 0.5×	18	465
Anfisa Stanevsky Israel	10	160 0.7×	272 1.3×	130 1.5×	131 1.6×	20 0.3×	13	543
Clara Di Mario Italy	14	190 0.8×	141 0.7×	34 0.4×	47 0.6×	20 0.3×	39	473
Thomas Grader‐Beck United States	13	146 0.6×	151 0.7×	37 0.4×	28 0.3×	85 1.4×	30	537
Rasho Rashkov Bulgaria	12	250 1.1×	173 0.8×	47 0.6×	47 0.6×	13 0.2×	47	475
Viviana Antonella Pacucci Italy	9	302 1.3×	208 1.0×	92 1.1×	31 0.4×	18 0.3×	17	466
Stinne Ravn Greisen Denmark	13	158 0.7×	266 1.3×	35 0.4×	45 0.6×	42 0.7×	36	622
Cleonice Bueno Brazil	15	316 1.4×	229 1.1×	37 0.4×	67 0.8×	14 0.2×	40	630

Countries citing papers authored by J.M. van Laar

Since Specialization

Citations

This map shows the geographic impact of J.M. van Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. van Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. van Laar more than expected).

Fields of papers citing papers by J.M. van Laar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. van Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. van Laar. The network helps show where J.M. van Laar may publish in the future.

Co-authorship network of co-authors of J.M. van Laar

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. van Laar. A scholar is included among the top collaborators of J.M. van Laar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. van Laar. J.M. van Laar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldschmeding, Roel, et al.. (2024). Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment. Lara D. Veeken. 64(6). 3957–3963. 1 indexed citations

Voortman, Mareye, H. Wouter van Es, Lucianne C.M. Langezaal, et al.. (2023). Prognostication of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung diseases: A cohort study. Frontiers in Medicine. 10. 1106560–1106560. 8 indexed citations

Laken, Conny J. van der, Gerben J.C. Zwezerijnen, Esther J. Nossent, et al.. (2022). Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation. Frontiers in Immunology. 13. 923869–923869. 3 indexed citations

Spierings, Julia, et al.. (2021). Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases. Respiratory Medicine. 187. 106579–106579. 31 indexed citations

Spierings, Julia, Arwen H. Pieterse, Madelon C Vonk, et al.. (2020). From “being at war” to “getting back on your feet”: A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation. Journal of Scleroderma and Related Disorders. 5(3). 202–209. 5 indexed citations

Spierings, Julia, Anne A. Schouffoer, J.M. van Laar, et al.. (2019). SAT0259 PREDICTIVE FACTORS FOR TREATMENT RELATED MORTALITY AND MAJOR ADVERSE EVENTS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SYSTEMIC SCLEROSIS: RESULTS OF A LONG TERM FOLLOW-UP MULTI-CENTRE STUDY. Annals of the Rheumatic Diseases. 78. 1206–1206. 1 indexed citations

Otten, Henny G., et al.. (2017). Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?. PubMed. 35(3). 462–470. 10 indexed citations

Vulpen, Lize F. D. van, M. E. R. van Meegeren, K. Coeleveld, et al.. (2017). A fusion protein of interleukin‐4 and interleukin‐10 protects against blood‐induced cartilage damage in vitro and in vivo. Journal of Thrombosis and Haemostasis. 15(9). 1788–1798. 19 indexed citations

Abheiden, Carolien N. H., J.M. van Laar, Irene E. M. Bultink, et al.. (2017). Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study. Journal of Immunology Research. 2017. 1–9. 26 indexed citations

10.

Hair, Maria J. H. de, Maarten Limper, A. Titia Lely, et al.. (2017). Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. Journal of Immunology Research. 2017. 1–5. 40 indexed citations

11.

Schutgens, Roger E. G., et al.. (2016). A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo. Osteoarthritis and Cartilage. 24. S505–S505. 9 indexed citations

12.

Jacobs, J. W. G., Rinie Geenen, A.C. Marijnissen, et al.. (2014). FRI0024 Contribution of the Individual Components of the Disease Activity Score (DAS28) to the Total DAS28 Score among Responders and Non-Responders to Biological Therapy for Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 73. 389–390. 1 indexed citations

13.

Vulpen, Lize F. D. van, M. E. R. van Meegeren, G. Roosendaal, et al.. (2014). Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study. Osteoarthritis and Cartilage. 23(1). 63–69. 49 indexed citations

14.

Landewé, Robert, J. G. A. Houbiers, Filip Van den Bosch, et al.. (2009). Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial. Annals of the Rheumatic Diseases. 69(9). 1655–1659. 14 indexed citations

15.

Burgoyne, C H, Sarah Field, Andrew K. Brown, et al.. (2007). Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse. Annals of the Rheumatic Diseases. 67(6). 750–757. 37 indexed citations

16.

Kroft, Lucia J.M., P. C. M. Simons, J.M. van Laar, & Andreas Roos. (2000). Patients with Pulmonary Fibrosis: Cardiac Function Assessed with MR Imaging. Radiology. 216(2). 464–471. 13 indexed citations

17.

Laar, J.M. van, A. M. M. Miltenburg, Angela Leow, et al.. (1993). Activated Synovial T Cell Clones from a Patient with Rheumatoid Arthritis Induce Proliferation of Autologous Peripheral Blood-Derived T Cells. Cellular Immunology. 146(1). 71–79. 3 indexed citations

18.

Miltenburg, A. M. M., J.M. van Laar, Ronella de Kuiper, M. R. Daha, & F. C. Breedveld. (1992). T Cells Cloned from Human Rheumatoid Synovial Membrane Functionally Represent the Th 1 Subset. Scandinavian Journal of Immunology. 35(5). 603–610. 154 indexed citations

19.

Miltenburg, A. M. M., J.M. van Laar, Ronella de Kuiper, M. R. Daha, & F C Breedveld. (1991). INTERLEUKIN-6 ACTIVITY IN PAIRED SAMPLES OF SYNOVIAL FLUID. CORRELATION OF SYNOVIAL FLUID INTERLEUKIN—6 LEVELS WITH CLINICAL AND LABORATORY PARAMETERS OF INFLAMMATION. Lara D. Veeken. 30(3). 186–189. 28 indexed citations

20.

Miltenburg, A. M. M., J.M. van Laar, Patricia Kuiper, M. R. Daha, & F. C. Breedveld. (1990). Cytolytic activity in T cell clones derived from human synovial rheumatoid membrane: inhibition by synovial fluid. Clinical & Experimental Immunology. 82(3). 499–503. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact